Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mader, I.
Right arrow Articles by Grodd, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mader, I.
Right arrow Articles by Grodd, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 124, No. 5, 953-961, May 2001
© 2001 Oxford University Press

Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis

I. Mader1, U. Seeger1, R. Weissert3, U. Klose1, T. Naegele2, A. Melms3 and W. Grodd1

1 Section for Experimental Magnetic Resonance of the Central Nervous System of the 2 Department of Neuroradiology and 3 Neurology, Eberhard-Karls University, Tübingen, Germany

Correspondence to: Irina Mader, Section for Experimental Magnetic Resonance of the Central Nervous System, Department of Neuroradiology, Eberhard-Karls University School of Medicine, Hoppe-Seyler-Strasse 3, D-72076 Tübingen, Germany E-mail: irina.mader@med.uni-tuebingen.de

Proton magnetic resonance spectroscopy has shown elevated signals in the spectral region of lipids in acute multiple sclerosis lesions. The metabolite-nulling technique allows the separation of macromolecules from other metabolites, such as lactate, N-acetyl-aspartate, creatine, choline and myo-inositol. Using this technique in studies on multiple sclerosis patients, we were able to differentiate macromolecules biochemically in acute and chronic multiple sclerosis lesions. Ten patients with acute, contrast-enhancing multiple sclerosis lesions, 10 patients with chronic lesions and 10 healthy control subjects were investigated with a 1.5 T whole body system, using a stimulated echo acquisition mode (STEAM) sequence with metabolite-nulling and outer volume saturation. Metabolites and macromolecules were quantitated absolutely. The 0.9 and 1.3 parts per million (p.p.m.) resonances of the macromolecules were significantly elevated in acute lesions compared with chronic lesions and healthy controls (P < 0.001 for 0.9 p.p.m., P < 0.05 for 1.3 p.p.m.). The macromolecular resonances at 2.1 and 3.0 p.p.m. in acute and chronic lesions were normal. N-acetyl-aspartate was significantly reduced in acute and chronic lesions compared with controls (P < 0.05 and P < 0.01, respectively). Choline was significantly elevated in acute lesions compared with controls (P < 0.05). Up to now, elevated resonances at 0.9 and 1.3 p.p.m. in acute lesions have been interpreted as lipids. In metabolite-nulled spectra, the macromolecular resonances did not fit those of lipids and might have been due to proteins or polypeptides containing the amino acids alanine, threonine, valine, leucine and isoleucine. These account for ~40% of the amino acids of myelin proteolipid protein and for ~20% of myelin basic protein. The increased macromolecular resonances at 0.9 and 1.3 p.p.m. may be interpreted as biochemical markers of myelin fragments and may be used as reliable markers of acute multiple sclerosis lesions as they provide clear discrimination among acute and chronic lesions and controls.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
J. F. A. Jansen, W. H. Backes, K. Nicolay, and M. E. Kooi
1H MR Spectroscopy of the Brain: Absolute Quantification of Metabolites.
Radiology, August 1, 2006; 240(2): 318 - 332.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
Z. Caramanos, S. Narayanan, and D. L. Arnold
1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review
Brain, November 1, 2005; 128(11): 2483 - 2506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J. P. Kim, M. R. Lentz, S. V. Westmoreland, J. B. Greco, E. M. Ratai, E. Halpern, A. A. Lackner, E. Masliah, and R. G. Gonzalez
Relationships between Astrogliosis and 1H MR Spectroscopic Measures of Brain Choline/Creatine and Myo-Inositol/Creatine in a Primate Model
AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 752 - 759.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
G. Sanacora, R. Gueorguieva, C. N. Epperson, Y.-T. Wu, M. Appel, D. L. Rothman, J. H. Krystal, and G. F. Mason
Subtype-Specific Alterations of {gamma}-Aminobutyric Acid and Glutamate in Patients With Major Depression
Arch Gen Psychiatry, July 1, 2004; 61(7): 705 - 713.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.